Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanosonics Limited (AU:NAN)
ASX:NAN
NAN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$2.59 - AU$4.72
Previous CloseN/A
Volume330.71K
Average Volume (3M)561.27K
Market Cap
$1.29B
Enterprise ValueAU$812.43M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)82.8
Beta0.43
Next Earnings
Sep 01, 2025EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding303,547,670
10 Day Avg. Volume783,746
30 Day Avg. Volume561,268
Standard Deviation0.13
R-Squared0.32
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.72Price Target Upside-17.64% Downside
Rating ConsensusHold
Number of Analyst Covering6
---
Nanosonics Limited News
PremiumCompany Announcements
Nanosonics Limited Reports Robust Growth and Strategic Progress
PremiumCompany Announcements
Nanosonics Limited Reports Strong Half-Year Earnings
PremiumCompany Announcements
Nanosonics Reports Strong 2025 Half-Year Financial Results
PremiumCompany Announcements
Nanosonics Reports Strong Half-Year Financial PerformancePremiumCompany Announcements
ECP Asset Management Increases Stake in Nanosonics
PremiumCompany Announcements
Mitsubishi UFJ Financial Group Reduces Stake in Nanosonics Limited
PremiumCompany Announcements
Nanosonics to Announce FY25 Half-Year Financial Results
---
Options Prices
Currently, No data available
---
Ownership Overview
0.61% Insiders
2.77% Mutual Funds
0.03% Other Institutional Investors
94.13% Public Companies and
Individual Investors
NAN FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest share price was AU$2.59 and its highest was AU$4.72 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is $1.29B.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Sep 01, 2025 which is in 191 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Feb 20, 2025. The company reported AU$0.032 earnings per share for the quarter, beating the consensus estimate of AU$0.022 by AU$0.01.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Overvalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.03.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 303,547,670 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of AU$0.032 in its last earnings report, beating expectations of AU$0.022. Following the earnings report the stock price went up 23.121%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in AU:NAN
---
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$3.72 (-17.64% Downside)
AU$3.72 (-17.64% Downside)
Blogger Sentiment
Bullish
AU:NAN Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.34%
12-Months-Change
Fundamentals
Return on Equity
9.23%
Trailing 12-Months
Asset Growth
1.89%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
---
NAN Company Deck
---
NAN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive performance with substantial revenue growth, particularly in North America and Europe. While challenges exist in European installations and regulatory delays in Japan, the company's financial health and strategic region-focused growth remain strong.Read More>---
NAN Stock 12 Month Forecast
Average Price Target
AU$3.72
▼(-17.64% Downside)
Technical Analysis
Cochlear Limited
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Ramsay Health Care
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering NAN
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+0.45%
reiterated a buy rating 6 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +0.45% per trade.
---